Nov 13, 2025 01:00AM
Nov 10, 2025 01:01AM
Nov 10, 2025 01:00AM
Oct 14, 2025 01:00AM
Sep 17, 2025 01:00AM
May 23, 2025 01:00AM
May 13, 2025 01:00AM Innate Pharma Reports First Quarter 2025 Business Update and Financial Results
Apr 16, 2025 01:00AM
Mar 27, 2025 02:00AM
Feb 17, 2025 01:02AM
Jan 21, 2025 01:00AM
Dec 9, 2024 01:00AM
Dec 3, 2024 01:00AM
Nov 13, 2024 01:00AM Innate Pharma Reports Third Quarter 2024 Business Update and Financial Results
Sep 23, 2024 01:00AM
Sep 12, 2024 01:00AM
Jun 17, 2024 01:00AM
Jun 4, 2024 01:00AM
May 21, 2024 01:00AM
May 14, 2024 01:00AM
Apr 15, 2024 01:00AM Innate Pharma Announces Advancement of Sanofi-developed NK Cell Engager SAR443579 / IPH6101 Progressing to Phase 2 for Blood Cancer Patients
Mar 21, 2024 02:00AM
Jan 4, 2024 01:00AM
Dec 11, 2023 01:00AM
Dec 10, 2023 01:00AM
Nov 27, 2023 01:00AM
Nov 14, 2023 01:00AM
Oct 5, 2023 01:00AM Innate Pharma Provides Update on Lacutamab Clinical Program
Sep 22, 2023 01:00AM
Sep 14, 2023 01:00AM
Jun 16, 2023 01:00AM
Jun 12, 2023 01:00AM
Jun 8, 2023 01:00AM
Jun 8, 2023 01:00AM
Dec 10, 2022 10:00AM Innate Pharma Presents Data From Ongoing Phase 2 TELLOMAK Trial Demonstrating Clinical Activity of Lacutamab in Advanced Sézary Syndrome at ASH 2022
Nov 4, 2022 02:00AM
Mar 18, 2021 02:00AM
Dec 11, 2020 01:00AM
Dec 3, 2020 08:30AM
Dec 2, 2020 01:00AM
Nov 17, 2020 01:00AM
Nov 13, 2020 01:00AM Innate Pharma Receives Prime Designation From the European Medicines Agency for Lacutamab in Sézary Syndrome
Nov 12, 2020 01:00AM
Oct 23, 2020 01:00AM
Oct 13, 2020 01:00AM
Sep 8, 2020 01:00AM
Sep 4, 2020 01:00AM
Aug 11, 2020 01:00AM
Jul 29, 2020 05:30AM Innate Pharma Announces Publication of EXPLORE COVID-19 Translational Study Findings in Nature
Jul 16, 2020 01:00AM

312,667 total articles have been posted to this entity.

Click Here to Sign-Up for StreetInsider.com Premium to View All